336
Participants
Start Date
April 30, 2009
Primary Completion Date
August 31, 2011
Placebo
AEB071
Virginia Clinical Research, Norfolk
Palmetto Clinical Trial Services, Greenville
Belleair Research Center, LLC, Pinellas Park
Dermatology Specialists, Louisville
Central Dermatology, St Louis
Kansas City Dermatology, PA, Overland Park
Burke Pharmaceutical Research, Hot Springs
Center for Clinical Studies, Houston
Suzanne Bruce & Associates, PA, Houston
Massachusetts General Hospital, Boston
Novartis Investigative site, Buenos Aires
Novartis Investigative site, Mendoza
Novartis Investigative site, Benowa
Novartis Investigative site, Carlton
Novartis Investigative site, Kogarah
Novartis Investigative site, Parkville
Novartis Investigative site, Brussels
Novartis Investigative site, Edegem
Novartis Investigative site, Liège
Novartis Investigative site, Berlin
Novartis Investigative site, Bonn
Novartis Investigative site, Erlangen
Novartis Investigative site, Frankfurt
Novartis Investigative site, Hamburg
Novartis Investigative site, Kiel
Novartis Investigative site, Leipzig
Novartis Investigative site, Regensburg
Novartis Investigative Site, Guatemala City
Novartis Investigative site, Milan
Novartis Investigative Site, Modena
Novartis Investigative Site, Rome
Novartis Investigative Site, Siena
Novartis Investigative Site, Verona
Novartis Investigative Site, Ankara
Novartis Investigative Site, Gaziantep
Novartis Investigative Site, Izmir
Novartis Investigative Site, Manisa
Novartis Investigative site, Nuneaton
Novartis Investigative site, Salford
Novartis Investigative site, Southampton
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY